Eighth Annual International Axon Degeneration Conference

Description

Axon degeneration underlies symptoms of many neurodegenerative diseases and currently the underlying mechanisms are poorly understood and effective therapies that prevent axon degeneration are not available. The Eighth Annual Axon Degeneration Conference will bring investigators from multiple institutions together to discuss the advances made in the past five years in the field. The focus will be on basic mechanisms of axon degeneration, disease relevance and potential therapeutic developments.

Director:

• Ahmet Hoke, professor of neurology, Johns Hopkins University

Speakers:

• Jeremy Sullivan, assistant professor of neurology, Johns Hopkins
• Vassilis Koliatsos, professor of pathology, Johns Hopkins
• Alexandra Byrne, assistant professor, Department of Neurobiology, UMass Chan Medical School
• Bogdan Beirowski, associate professor, Department of Neurology, College of Medicine, The Ohio State University
• Robert Burgess, professor, The Jackson Laboratory
• Andrea Cortese, academic neurologist, UCL Institute of Neurology, MRC Centre for Neuromuscular Disease +Aaron DiAntonio, professor of developmental biology, Department of Developmental Biology, Washington University School of Medicine
• Robert Fledrich, professor, Institute of Anatomy, University of Leipzig
• Marc Freeman, director and professor, Vollum Institute, Oregon Health & Science University +Jonathan Gilley, senior research associate, John van Geest Brain Repair Centre, University of Cambridge +Erika Holzbaur, professor of physiology, Perelman School of Medicine, University of Pennsylvania
• Claire Le Pichon, investigator, Development of Neurodegeneration Unit, National Institute of Health
• Andrea Loreto, research fellow, Save Sight Institute, School of Medical Sciences, University of Sydney
• Sonia Mayoral, assistant professor, Carney Institute for Brain Science, Brown University
• Jeffrey Milbrandt, professor, Department of Genetics, and executive director, McDonnell Genome Institute, Washington University School of Medicine
• Lukas Neukomm, assistant professor, Department of Neurosciences, University of Lausanne
• Rosalind Segal, professor of neurobiology, Harvard Medical School
• Grace Shin, assistant professor of neurology, Ohio State University
• Michael Shy, professor, Departments of Neurology, Pediatrics, and Neuroscience, University of Iowa
• Ruth Stassart, professor for translational neuropathology, Paul-Flechsig-Institute of Neuropathology, Leipzig University
• Vinod Sundaramoorthy, research fellow of viral neuropathogenesis, Deakin University and CSIRO
• Stephan Zuchner, professor, Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami

Guest Speakers for Non-CME Session:

• Bradlee Heckmann, scientific co-founder and chief scientific officer, Asha Therapeutics
• Raul Krauss, senior vice president, cofounder, and head of biology, Disarm Therapeutics (a wholly owned subsidiary of Eli Lilly & Co.)
• Joseph Lewcock, chief scientific officer and head of discovery, Denali Therapeutics
• Shilpa Sambashivan, chief scientific officer, Nura Bio